{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:35:56Z","timestamp":1784608556474,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08864"],"award-info":[{"award-number":["23K08864"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K02586"],"award-info":[{"award-number":["24K02586"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K02414"],"award-info":[{"award-number":["25K02414"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K12699"],"award-info":[{"award-number":["25K12699"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004823","name":"Nagoya University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018117","name":"Aichi Health Promotion Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.placenta.2025.11.012","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T04:29:13Z","timestamp":1764390553000},"page":"9-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Natural-killer-cell\u2013dominant immune landscape and HLA-E\u2013mediated immune evasion in choriocarcinoma"],"prefix":"10.1016","volume":"174","author":[{"given":"Mayu","family":"Shibata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1484-4872","authenticated-orcid":false,"given":"Kosuke","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nishiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kae","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Koya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiro","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kajiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2025.11.012_bib1","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.3802\/jgo.2022.33.e72","article-title":"Epidemiologic study on gestational trophoblastic diseases in Japan","volume":"33","author":"Yamamoto","year":"2022","journal-title":"J. Gynecol. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.placenta.2025.11.012_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ijgo.13877","article-title":"Diagnosis and management of gestational trophoblastic disease: 2021 update","volume":"155","author":"Ngan","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.placenta.2025.11.012_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/sj.bjc.6603608","article-title":"A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia","volume":"96","author":"Powles","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.placenta.2025.11.012_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10147-019-01540-9","article-title":"The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia","volume":"25","author":"Sato","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.placenta.2025.11.012_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-022-01282-8","article-title":"Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets","volume":"15","author":"Tie","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.placenta.2025.11.012_bib6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","article-title":"Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.placenta.2025.11.012_bib7","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/S0140-6736(17)32894-5","article-title":"Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia","volume":"390","author":"Ghorani","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.placenta.2025.11.012_bib8","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1200\/JCO.2017.74.4052","article-title":"Complete serologic response to pembrolizumab in a woman with chemoresistant metastatic choriocarcinoma","volume":"35","author":"Huang","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.placenta.2025.11.012_bib9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S1470-2045(21)00460-5","article-title":"Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial","volume":"22","author":"Cheng","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.placenta.2025.11.012_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1078-0432.CCR-23-2293","article-title":"A phase II basket trial of dual Anti-CTLA-4 and Anti-PD-1 blockade in rare tumors (DART SWOG 1609 cohort 47) in patients with gestational trophoblastic neoplasia","volume":"30","author":"Patel","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.placenta.2025.11.012_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155120","article-title":"Natural killer cell-mediated immune surveillance in cancer: role of tumor microenvironment","volume":"254","author":"Saadh","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.placenta.2025.11.012_bib12","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41419-024-06976-0","article-title":"Natural killer cells at the frontline in the fight against cancer","volume":"15","author":"Co\u00ebnon","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.placenta.2025.11.012_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2567.2008.03019.x","article-title":"Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies","volume":"127","author":"Apps","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.placenta.2025.11.012_bib14","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.7150\/ijbs.73616","article-title":"Human leukocyte antigens: the unique expression in trophoblasts and their crosstalk with local immune cells","volume":"18","author":"Lin","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.placenta.2025.11.012_bib15","article-title":"Core 2 \u03b21,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity","volume":"26","author":"Nakamura","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.placenta.2025.11.012_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101557","article-title":"Isolation of tumor-infiltrating lymphocytes from preserved human tumor tissue specimens for downstream characterization","volume":"3","author":"Kobayashi","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.placenta.2025.11.012_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.placenta.2025.11.012_bib18","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1245\/s10434-022-12505-0","article-title":"Dynamic alteration in HLA-E expression and soluble HLA-E via interaction with natural killer cells in gastric cancer","volume":"30","author":"Morinaga","year":"2023","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.placenta.2025.11.012_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009410","article-title":"IFN\u03b3 mediates the resistance of tumor cells to distinct NK cell subsets","volume":"12","author":"Hofman","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.placenta.2025.11.012_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/tan.12478","article-title":"Clinical and immunological significance of HLA-E in stem cell transplantation and cancer","volume":"84","author":"Wieten","year":"2014","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.placenta.2025.11.012_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nri2604","article-title":"Oncogenic stress sensed by the immune system: role of natural killer cell receptors","volume":"9","author":"Raulet","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.placenta.2025.11.012_bib22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ygyno.2020.11.005","article-title":"Immune cell composition in the endometrium of patients with a complete molar pregnancy: effects on outcome","volume":"160","author":"Hoeijmakers","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.placenta.2025.11.012_bib23","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0198-8859(00)00201-9","article-title":"Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines","volume":"61","author":"Sivori","year":"2000","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.placenta.2025.11.012_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1571857","article-title":"A novel NKG2A alpaca nanobody targeting immune checkpoint blockade for the treatment of malignant melanoma","volume":"12","author":"Guo","year":"2025","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.placenta.2025.11.012_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn2811","article-title":"SMARCA4 regulates the NK-mediated killing of senescent cells","volume":"11","author":"Reen","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.placenta.2025.11.012_bib26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1158\/0008-5472.CAN-25-0831","article-title":"Combining STING agonists with PARP inhibitors mounts an NK-Dependent defense against therapy-resistant breast cancer","volume":"85","author":"Gohari","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.placenta.2025.11.012_bib27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/cei.13407","article-title":"TIGIT as an emerging immune checkpoint","volume":"200","author":"Harjunp\u00e4\u00e4","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.placenta.2025.11.012_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13045-022-01382-5","article-title":"Natural killer cells in clinical development as non-engineered, engineered, and combination therapies","volume":"15","author":"Lamers-Kok","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.placenta.2025.11.012_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andr\u00e9","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.placenta.2025.11.012_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2025.104554","article-title":"A phase II study of monalizumab and durvalumab in patients with recurrent\/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)","volume":"10","author":"Galot","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.placenta.2025.11.012_bib31","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1158\/1078-0432.CCR-25-0073","article-title":"INTERLINK-1: a phase III, randomized, placebo-controlled study of monalizumab plus cetuximab in recurrent\/metastatic head and neck squamous cell carcinoma","volume":"31","author":"Fayette","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.placenta.2025.11.012_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081822","article-title":"How chemotherapy affects the tumor immune microenvironment: a narrative review","volume":"10","author":"Merlano","year":"2022","journal-title":"Biomedicines"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425007489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400425007489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:31:15Z","timestamp":1773837075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400425007489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"alternative-id":["S0143400425007489"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2025.11.012","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural-killer-cell\u2013dominant immune landscape and HLA-E\u2013mediated immune evasion in choriocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2025.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}